179 related articles for article (PubMed ID: 37978469)
1. Expression and gene regulatory network of S100A16 protein in cervical cancer cells based on data mining.
Zhang H; Yang Y; Xing W; Li Y; Zhang S
BMC Cancer; 2023 Nov; 23(1):1124. PubMed ID: 37978469
[TBL] [Abstract][Full Text] [Related]
2. S100A16 up-regulates Oct4 and Nanog expression in cancer stem-like cells of Yumoto human cervical carcinoma cells.
Tomiyama N; Ikeda R; Nishizawa Y; Masuda S; Tajitsu Y; Takeda Y
Oncol Lett; 2018 Jun; 15(6):9929-9933. PubMed ID: 29928366
[TBL] [Abstract][Full Text] [Related]
3. S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma.
Sapkota D; Bruland O; Parajuli H; Osman TA; Teh MT; Johannessen AC; Costea DE
BMC Cancer; 2015 Sep; 15():631. PubMed ID: 26353754
[TBL] [Abstract][Full Text] [Related]
4. S100A16, a ubiquitously expressed EF-hand protein which is up-regulated in tumors.
Marenholz I; Heizmann CW
Biochem Biophys Res Commun; 2004 Jan; 313(2):237-44. PubMed ID: 14684152
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
Tanaka M; Ichikawa-Tomikawa N; Shishito N; Nishiura K; Miura T; Hozumi A; Chiba H; Yoshida S; Ohtake T; Sugino T
BMC Cancer; 2015 Feb; 15():53. PubMed ID: 25884418
[TBL] [Abstract][Full Text] [Related]
6. S100A16, a novel calcium-binding protein of the EF-hand superfamily.
Sturchler E; Cox JA; Durussel I; Weibel M; Heizmann CW
J Biol Chem; 2006 Dec; 281(50):38905-17. PubMed ID: 17030513
[TBL] [Abstract][Full Text] [Related]
7. S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.
Zhu W; Xue Y; Liang C; Zhang R; Zhang Z; Li H; Su D; Liang X; Zhang Y; Huang Q; Liu M; Li L; Li D; Zhao AZ; Liu Y
Tumour Biol; 2016 Sep; 37(9):12241-12250. PubMed ID: 27240591
[TBL] [Abstract][Full Text] [Related]
8. Calbindin S100A16 Promotes Renal Cell Carcinoma Progression and Angiogenesis via the VEGF/VEGFR2 Signaling Pathway.
Wang N; Wang R; Tang J; Gao J; Fang Z; Zhang M; Shen X; Lu L; Chen Y
Contrast Media Mol Imaging; 2022; 2022():5602011. PubMed ID: 36176934
[TBL] [Abstract][Full Text] [Related]
9. Molecular modeling of single polypeptide chain of calcium-binding protein p26olf from dimeric S100B(betabeta).
Tanaka T; Miwa N; Kawamura S; Sohma H; Nitta K; Matsushima N
Protein Eng; 1999 May; 12(5):395-405. PubMed ID: 10360980
[TBL] [Abstract][Full Text] [Related]
10. Identification of S100A16 as a novel adipogenesis promoting factor in 3T3-L1 cells.
Liu Y; Zhang R; Xin J; Sun Y; Li J; Wei D; Zhao AZ
Endocrinology; 2011 Mar; 152(3):903-11. PubMed ID: 21266506
[TBL] [Abstract][Full Text] [Related]
11. S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathways.
Fang D; Zhang C; Xu P; Liu Y; Mo X; Sun Q; Abdelatty A; Hu C; Xu H; Zhou G; Xia H; Lan L
Cell Biol Toxicol; 2021 Aug; 37(4):555-571. PubMed ID: 33389337
[TBL] [Abstract][Full Text] [Related]
12. S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine.
Li T; Ren T; Huang C; Li Y; Yang P; Che G; Luo L; Chen Y; Peng S; Lin Y; Zeng L
Biochem Pharmacol; 2021 Jul; 189():114396. PubMed ID: 33359364
[TBL] [Abstract][Full Text] [Related]
13. S100A14 interacts with S100A16 and regulates its expression in human cancer cells.
Sapkota D; Costea DE; Ibrahim SO; Johannessen AC; Bruland O
PLoS One; 2013; 8(9):e76058. PubMed ID: 24086685
[TBL] [Abstract][Full Text] [Related]
14. An Update on S100A16 in Human Cancer.
Basnet S; Vallenari EM; Maharjan U; Sharma S; Schreurs O; Sapkota D
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509106
[TBL] [Abstract][Full Text] [Related]
15. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
Chen D; Luo L; Liang C
PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
[TBL] [Abstract][Full Text] [Related]
16. S100 Calcium Binding Protein A16 Promotes Cell Proliferation by triggering LATS1 ubiquitin degradation mediated by CUL4A ligase to inhibit Hippo pathway in Glioma development.
Hu Y; Zhang R; Lu S; Zhang W; Wang D; Ge Y; Jiang F; Qin X; Liu Y
Int J Biol Sci; 2023; 19(7):2034-2052. PubMed ID: 37151881
[No Abstract] [Full Text] [Related]
17. S100A16 suppresses the growth and survival of leukaemia cells and correlates with relapse and relapse free survival in adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia.
Zhang J; Lu WY; Zhang JM; Lu RQ; Wu LX; Qin YZ; Liu YR; Lai YY; Jiang H; Jiang Q; Jiang B; Xu LP; Zhang XH; Huang XJ; Ruan GR; Liu KY
Br J Haematol; 2019 Jun; 185(5):836-851. PubMed ID: 30916375
[TBL] [Abstract][Full Text] [Related]
18. S100A16 suppresses the proliferation, migration and invasion of colorectal cancer cells in part via the JNK/p38 MAPK pathway.
Ou S; Liao Y; Shi J; Tang J; Ye Y; Wu F; Wang W; Fei J; Xie F; Bai L
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355370
[TBL] [Abstract][Full Text] [Related]
19. S100A16 is a prognostic marker for colorectal cancer.
Sun X; Wang T; Zhang C; Ning K; Guan ZR; Chen SX; Hong TT; Hua D
J Surg Oncol; 2018 Feb; 117(2):275-283. PubMed ID: 28876468
[TBL] [Abstract][Full Text] [Related]
20. Structural characterization of human S100A16, a low-affinity calcium binder.
Babini E; Bertini I; Borsi V; Calderone V; Hu X; Luchinat C; Parigi G
J Biol Inorg Chem; 2011 Feb; 16(2):243-56. PubMed ID: 21046186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
